Indeed a review article concluded that in prospective trials, therapeutic doses of paracetamol do not cause toxicity, and notes that only in retrospective studies does therapeutic toxicity occur and this is likely due to the biases inherent in retrospective analysis [2, 6, 7]
That's not a supplier problemit's a systems problem, and it's fixable with three changes: aliquoting immediately after reconstitution, logging temperature continuously, and never injecting air into the vial
In one prospective cohort study of CKD patients, mortality risk was 2.8 times higher in those with higher TMAO levels In another study, patients with end-stage renal disease on dialysis had TMAO levels forty times higher than the control group (Hai et al
These strategies not only protect individual participants but also enhance the overall quality and validity of the study data
SLC7A11 is the primary transporter protein, highly specific for cystine and glutamate, while SLC3A2 is a chaperone
